ovarian cancer
Showing NaN - NaN of 91
Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and
Completed
- Cervical Cancer
- +16 more
- INCAGN02385
-
Los Angeles, California
- +3 more
Oct 28, 2020
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Ovarian Cancer Trial in United States (Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD), Topotecan)
Completed
- Ovarian Cancer
- Lurbinectedin (PM01183)
- +2 more
-
Peoria, Arizona
- +27 more
Mar 25, 2020
Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)
Ovarian Cancer Trial in Phoenix, Detroit, Nashville (VAL-083, Dianhydrogalactitol)
Withdrawn
- Ovarian Cancer
- VAL-083, Dianhydrogalactitol
-
Phoenix, Arizona
- +2 more
Oct 16, 2019
Ovarian Cancer Trial in United States (SC-003, SC-003 in combination with ABBV-181)
Terminated
- Ovarian Cancer
- SC-003
- SC-003 in combination with ABBV-181
-
Fayetteville, Arkansas
- +15 more
Jan 2, 2019
Ovarian Cancer Trial in Worldwide (Pimasertib once daily, Pimasertib , SAR245409 )
Completed
- Ovarian Cancer
- Pimasertib once daily
- +4 more
-
Augusta, Georgia
- +33 more
Nov 26, 2018
Ovarian Cancer, Renal Cancer, NSCLC Trial in United States (Carfilzomib, Dexamethasone)
Completed
- Ovarian Cancer
- +6 more
-
Scottsdale, Arizona
- +6 more
Jul 14, 2017
Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer Trial in United States (STM 434, Liposomal doxorubicin)
Completed
- Ovarian Cancer
- +3 more
- STM 434
- Liposomal doxorubicin
-
Boston, Massachusetts
- +3 more
Feb 10, 2017
Ovarian Cancer Trial in United States (EMD 72000)
Completed
- Ovarian Cancer
- EMD 72000
-
Baltimore, Maryland
- +4 more
Jan 19, 2017
Tissue Samples From Stage III or Stage IV Ovarian Epithelial
Completed
- Ovarian Cancer
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 9, 2015
Ovarian Cancer Trial in Worldwide (MORAb-003 (farletuzumab), 0.9% Saline)
Completed
- Ovarian Cancer
- MORAb-003 (farletuzumab)
- 0.9% Saline
-
Birmingham, Alabama
- +374 more
Jun 25, 2015
Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Worldwide (cetuximab, carboplatin)
Completed
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
- cetuximab
- carboplatin
-
Birmingham, Alabama
- +75 more
Feb 12, 2014
Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Worldwide (gefitinib)
Completed
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
-
Birmingham, Alabama
- +52 more
Jun 20, 2013
Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Canada, United States (aminocamptothecin colloidal dispersion)
Completed
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
- aminocamptothecin colloidal dispersion
-
Birmingham, Alabama
- +64 more
Jun 20, 2013